ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Other languages Zylox-Tonbridge Medical Technology Co., Ltd.

Equities

2190

CNE100004JD2

Market Closed - Hong Kong S.E. Other stock markets 04:08:16 2024-04-24 am EDT			5-day change	1st Jan Change
10.5 ^HKD	+3.96%		+15.64%	-15.59%

Mar. 22	Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	MT
Mar. 21	Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	Mar. 22
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket	Mar. 07
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker	Mar. 07
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd	Mar. 06
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE	Feb. 21
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7%	Jan. 22
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System	Jan. 21
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System	Dec. 28
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany	Dec. 20
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval	Dec. 11
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.	Nov. 07
Zylox-Tonbridge Medical Technology Co., Ltd.'S ZENFlow Tiger? LD PTA Dilatation Catheter Receives ANVISA Marketing Approval	23-08-30
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23
Zylox-Tonbridge Medical Technology Shrinks 2022 Loss as Revenue Surges 88%	23-03-29
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29
Nmpa Granted Marketing Approval for Zylox Octoplus Retrievable Inferior Vena Cava Filter of Zylox-Tonbridge Medical Technology Co., Ltd	22-12-14
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Executive Changes	22-09-05
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15
China Grants Marketing Approval to Zylox-Tonbridge's Angioplasty Balloon Catheter	22-04-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zylox-Tonbridge Medical Technology Co., Ltd.

Equities

2190

CNE100004JD2

Other languages

Filters